May IL-17 have a role in COVID-19 infection?
M Megna, M Napolitano, G Fabbrocini - Medical hypotheses, 2020 - ncbi.nlm.nih.gov
SARS-Corona-Virus-2 related disease (COVID-19) which started in Wuhan, China on
December 2019, is spreading rapidly throughout the world [1]. COVID-19 clinical spectrum is …
December 2019, is spreading rapidly throughout the world [1]. COVID-19 clinical spectrum is …
The role of IL-6 in coronavirus, especially in COVID-19
X Wang, G Tang, Y Liu, L Zhang, B Chen… - Frontiers in …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects both people and
animals and may cause significant respiratory problems, including lung illness: Corona …
animals and may cause significant respiratory problems, including lung illness: Corona …
Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective
The newfound coronavirus disease 2019 (COVID-19), initiated by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …
Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action?
Interleukin (IL)-10 is a pleiotropic cytokine known for its potent anti-inflammatory and
immunosuppressive effects. Originally identified as a product of T helper 2 cells, IL-10 is now …
immunosuppressive effects. Originally identified as a product of T helper 2 cells, IL-10 is now …
Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients
Objective The hyperinflammatory response, caused by severe acute respiratory syndrome-2
(SARS-CoV-2), is the most common cause of death in patients with coronavirus disease …
(SARS-CoV-2), is the most common cause of death in patients with coronavirus disease …
A potential role of interleukin 10 in COVID-19 pathogenesis
L Lu, H Zhang, DJ Dauphars, YW He - Trends in Immunology, 2021 - cell.com
A unique feature of the cytokine storm in coronavirus disease 2019 (COVID-19) is the
dramatic elevation of interleukin 10 (IL-10). This was thought to be a negative feedback …
dramatic elevation of interleukin 10 (IL-10). This was thought to be a negative feedback …
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
H Satış, HS Özger, PA Yıldız, K Hızel, Ö Gulbahar… - Cytokine, 2021 - Elsevier
Background The effectual immune response is crucial to defeat viral infections. However,
exuberant immune response with features of macrophage activation syndrome (MAS) lead …
exuberant immune response with features of macrophage activation syndrome (MAS) lead …
[HTML][HTML] Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
GM Casillo, AA Mansour, F Raucci… - Pharmacological …, 2020 - ncbi.nlm.nih.gov
BALF, bronchoalveolar lavage fluid; COVID-19, Coronavirus disease-19; FDA, Food and
Drug Administration; G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte …
Drug Administration; G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte …
Relationship between IL-6 and COVID-19: to be considered during treatment
HS Vatansever, E Becer - Future Virology, 2020 - Taylor & Francis
The detection and control of pro-inflammatory response is crucial in the early stages of viral
infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global …
infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global …
COVID-19 infection: an overview on cytokine storm and related interventions
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …